938 related articles for article (PubMed ID: 33064267)
1. Neurological Involvements of SARS-CoV2 Infection.
Gasmi A; Tippairote T; Mujawdiya PK; Gasmi Benahmed A; Menzel A; Dadar M; Bjørklund G
Mol Neurobiol; 2021 Mar; 58(3):944-949. PubMed ID: 33064267
[TBL] [Abstract][Full Text] [Related]
2. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
[TBL] [Abstract][Full Text] [Related]
3. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.
Maury A; Lyoubi A; Peiffer-Smadja N; de Broucker T; Meppiel E
Rev Neurol (Paris); 2021; 177(1-2):51-64. PubMed ID: 33446327
[TBL] [Abstract][Full Text] [Related]
4. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 Infection and Guillain-Barré Syndrome: A Review on Potential Pathogenic Mechanisms.
Shoraka S; Ferreira MLB; Mohebbi SR; Ghaemi A
Front Immunol; 2021; 12():674922. PubMed ID: 34040615
[TBL] [Abstract][Full Text] [Related]
6. Spectrum of Neurological Manifestations in Covid-19: A Review.
Garg RK
Neurol India; 2020; 68(3):560-572. PubMed ID: 32643664
[TBL] [Abstract][Full Text] [Related]
7. Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic.
Dewanjee S; Vallamkondu J; Kalra RS; Puvvada N; Kandimalla R; Reddy PH
Mol Neurobiol; 2021 Sep; 58(9):4694-4715. PubMed ID: 34169443
[TBL] [Abstract][Full Text] [Related]
8. Encephalopathy and encephalitis during acute SARS-CoV-2 infection. Spanish Society of Neurology COVID-19 Registry.
Abenza Abildúa MJ; Atienza S; Carvalho Monteiro G; Erro Aguirre ME; Imaz Aguayo L; Freire Álvarez E; García-Azorín D; Gil-Olarte Montesinos I; Lara Lezama LB; Navarro Pérez MP; Pérez Sánchez JR; Romero Delgado F; Serrano Serrano B; Villarreal Vitorica E; Ezpeleta Echávarri D
Neurologia (Engl Ed); 2021 Mar; 36(2):127-134. PubMed ID: 33549369
[TBL] [Abstract][Full Text] [Related]
9. What can cerebrospinal fluid testing and brain autopsies tell us about viral neuroinvasion of SARS-CoV-2.
Li YC; Zhang Y; Tan BH
J Med Virol; 2021 Jul; 93(7):4247-4257. PubMed ID: 33724490
[TBL] [Abstract][Full Text] [Related]
10. Emerging neurotropic features of SARS-CoV-2.
Zhan WR; Huang J; Zeng PM; Tian WY; Luo ZG
J Mol Cell Biol; 2021 Dec; 13(10):705-711. PubMed ID: 34289037
[TBL] [Abstract][Full Text] [Related]
11. Cross-Talk Between Key Players in Patients with COVID-19 and Ischemic Stroke: A Review on Neurobiological Insight of the Pandemic.
Kaushik P; Kaushik M; Parveen S; Tabassum H; Parvez S
Mol Neurobiol; 2020 Dec; 57(12):4921-4928. PubMed ID: 32813238
[TBL] [Abstract][Full Text] [Related]
12. Overview of COVID-19 and neurological complications.
Hosseini N; Nadjafi S; Ashtary B
Rev Neurosci; 2021 Aug; 32(6):671-691. PubMed ID: 33583157
[TBL] [Abstract][Full Text] [Related]
13. Neurologic aspects of covid-19: a concise review.
Brouwer MC; Ascione T; Pagliano P
Infez Med; 2020 Jun; 28(suppl 1):42-45. PubMed ID: 32532937
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 and Neurological Impairment: Hypothalamic Circuits and Beyond.
Mussa BM; Srivastava A; Verberne AJM
Viruses; 2021 Mar; 13(3):. PubMed ID: 33802995
[TBL] [Abstract][Full Text] [Related]
15. Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review.
Montalvan V; Lee J; Bueso T; De Toledo J; Rivas K
Clin Neurol Neurosurg; 2020 Jul; 194():105921. PubMed ID: 32422545
[TBL] [Abstract][Full Text] [Related]
16. A Review of Neurological Involvement in Patients with SARS-CoV-2 Infection.
Xu Y; Zhuang Y; Kang L
Med Sci Monit; 2021 Jun; 27():e932962. PubMed ID: 34145211
[TBL] [Abstract][Full Text] [Related]
17. COVID-19: A Global Threat to the Nervous System.
Koralnik IJ; Tyler KL
Ann Neurol; 2020 Jul; 88(1):1-11. PubMed ID: 32506549
[TBL] [Abstract][Full Text] [Related]
18. Neurological manifestations and pathogenic mechanisms of COVID-19.
Galea M; Agius M; Vassallo N
Neurol Res; 2022 Jul; 44(7):571-582. PubMed ID: 34986754
[TBL] [Abstract][Full Text] [Related]
19. Neurological Sequelae of COVID-19.
Ahmad SJ; Feigen CM; Vazquez JP; Kobets AJ; Altschul DJ
J Integr Neurosci; 2022 Apr; 21(3):77. PubMed ID: 35633158
[TBL] [Abstract][Full Text] [Related]
20. Heralding Healthcare Professionals: Recognition of Neurological Deficits in COVID-19.
Baig AM; Sanders EC
ACS Chem Neurosci; 2020 Jun; 11(12):1701-1703. PubMed ID: 32469504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
